Role of NF‐κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Dermatology

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/ijd.12050PMID 23621342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines in psoriasis.

  2015cited by this paper
• PSORS2 is due to mutations in CARD14.

  2012cited by this paper
• The histopathology of psoriasis.

  2011cited by this paper
• Nuclear factor kappa-B and histopathology of chronic gastritis.

  2010cited by this paper
• NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis.

  2009cited by this paper
• CURRENT CONCEPTS IN THE PATHOGENESIS OF PSORIASIS

  2009cited by this paper
• Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.

  2008cited by this paper
• Evaluation of survivin and NF‐κB in psoriasis, an immunohistochemical study

  2008cited by this paper
• Nature of cell kinetics in psoriatic epidermis

  2007cited by this paper
• Impaired Langerhans cell migration in psoriasis

  2006cited by this paper
• Modulating TNF-alpha signaling with natural products.

  2006cited by this paper
• Modulating TNF-α signaling with natural products

  2006cited by this paper
• Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.

  2005cited by this paper
• Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.

  2005cited by this paper
• Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept

  2005cited by this paper
• Tumor necrosis factor-α-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor κB

  2005cited by this paper
• Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of Apoptosis*

  2004cited by this paper
• Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling*

  2004cited by this paper
• Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling.

  2004cited by this paper
• Evaluation of cell death and proliferation in psoriatic epidermis.

  2004cited by this paper
• The immunologic basis for the treatment of psoriasis with new biologic agents.

  2002cited by this paper
• Possible new role for NF-κB in the resolution of inflammation

  2001cited by this paper
• Possible new role for NF-kappaB in the resolution of inflammation.

  2001cited by this paper
• NF-κB: a key role in inflammatory diseases

  2001cited by this paper
• Cytokines in psoriasis

  1999cited by this paper
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases.

  1999cited by this paper
• Activators and target genes of Rel/NF-κB transcription factors

  1999cited by this paper
• AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis.

  1998cited by this paper
• Rel/NF-kappa B transcription factors and the control of apoptosis.

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• Rel/NF-κB transcription factors and the control of apoptosis

  1997cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• Structure, regulation and function of NF-kappa B.

  1994cited by this paper
• [Current concepts of the pathogenesis of psoriasis].

  1987cited by this paper

• Downregulation of RSAD2 ameliorates keratinocyte hyperproliferation and skin inflammation in psoriasis via the TAK1/NF-κB axis.

  2025cites this paper
• Targeting the epigenetic regulator bromodomain-containing protein 4 by BRD4 siRNA lipoplexes and PFI-1 in psoriasis.

  2025cites this paper
• Simultaneous targeting of multiple etiological using a nanosized strategy for psoriasis management

  2025cites this paper
• Transdermal Delivery of PCSK9 siRNA via Biomimetic Nanovesicle-Loaded Microneedles for Psoriasis Immunomodulation.

  2025cites this paper
• Silymarin exerts antipsoriatic effects against imiquimod-induced psoriasis in mice via NF-kB/TLR4 signaling pathway

  2025cites this paper
• The Therapeutic Potential of Extracellular Vesicles in Psoriasis Treatment: Mechanisms, Applications, and Prospects

  2025cites this paper
• Psoriasis unveiled: The cellular ballet, molecular symphony, and genetic puzzle.

  2025cites this paper
• TCN1 as an inflammatory regulator in psoriasis: Activation of the NF-κB pathway and potential therapeutic target.

  2025cites this paper
• Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-κB and MAPK Signaling Pathways

  2024cites this paper
• Oroxylin A attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization

  2024cites this paper
• Advances in psoriasis research: From pathogenesis to therapeutics.

  2024cites this paper
• Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study

  2024cites this paper
• Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis

  2024influential citation
• Eicosapentaenoic acid reduces the proportion of IL-17A–producing T cells in a 3D psoriatic skin model

  2023cites this paper
• Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo

  2023cites this paper
• Effect and mechanism of hydrogen‐rich bath on mice with imiquimod‐induced psoriasis

  2023cites this paper
• Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice

  2022cites this paper
• Five Rutaceae family ethanol extracts alleviate H2O2 and LPS-induced inflammation via NF-κB and JAK-STAT3 pathway in HaCaT cells.

  2022cites this paper
• Anti-Psoriatic Effect of Rheum palmatum L. and Its Underlying Molecular Mechanisms

  2022cites this paper
• Anti-inflammatory Effects of Topically Applied Azilsartan in a Mouse Model of Imiquimod-induced Psoriasis

  2022cites this paper
• Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis.

  2022cites this paper
• DNA Methylation Expression Profile of Blood Heat Syndrome and Blood Stasis Syndrome in TCM Psoriasis

  2022cites this paper
• Augmentation of NAD+ by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice

  2022cites this paper
• Intravenous As2O3 as a promising treatment for psoriasis — an experimental study in psoriasis-like mouse model

  2022cites this paper
• Antipsoriatic Potential of Quebecol and Its Derivatives

  2022cites this paper
• I-KappaB Expression in Patient with Psoriasis Vulgaris

  2022cites this paper
• Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in Mice

  2022cites this paper
• Activity of nuclear factor κB in lymphocyte populations of children with psoriasis

  2022cites this paper
• Cytokine induced 3‐D organotypic psoriasis skin model demonstrates distinct roles for NF‐κB and JAK pathways in disease pathophysiology

  2022cites this paper
• Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry

  2022cites this paper
• Immunohistochemical expression of cornulin in lesional and perilesional skin of plaque psoriasis

  2021cites this paper
• Paeoniflorin attenuates the allergic contact dermatitis response via inhibiting the IFN-γ production and the NF-κB/IκBα signaling pathway in T lymphocytes.

  2021cites this paper
• Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations

  2021cites this paper
• Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-κB and VEGFR2 signaling.

  2021cites this paper
• Metformin ameliorates animal models of dermatitis

  2020cites this paper
• Diterpenoids and Triterpenoids From Frankincense Are Excellent Anti-psoriatic Agents: An in silico Approach

  2020cites this paper
• NB‐UVB irradiation attenuates inflammatory response in psoriasis

  2020cites this paper
• Cytokines Driven Anti-Inflammatory and Anti-Psoriasis Like Efficacies of Nutraceutical Sea Buckthorn (Hippophae rhamnoides) Oil

  2019cites this paper
• Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.

  2019influential citation
• Pharmacological Effects of Withanolides

  2019cites this paper
• Homocysteine and psoriasis

  2019cites this paper
• Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis

  2018cites this paper
• Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson

  2018cites this paper
• Generalized pustular psoriasis: a review and update on treatment

  2018cites this paper
• Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?

  2018cites this paper
• Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target

  2018cites this paper
• Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS‐sirt1‐NF‐κB signaling

  2018cites this paper
• Aromatic‐turmerone ameliorates imiquimod‐induced psoriasis‐like inflammation of BALB/c mice

  2018cites this paper
• Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4+Foxp3+ Regulatory T Cells

  2018cites this paper
• Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?

  2018cites this paper
• NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant.

  2017cites this paper
• Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis

  2017cites this paper
• Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study.

  2017cites this paper
• Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review.

  2017cites this paper
• Oxidative stress in psoriasis and potential therapeutic use of antioxidants

  2016cites this paper
• Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol

  2016cites this paper
• Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.

  2015cites this paper
• NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

  2015cites this paper
• The IL-23/IL-17 axis in psoriatic arthritis.

  2014cites this paper
• Genetics of psoriatic arthritis.

  2014cites this paper
• Expression of tumor necrosis factor-α and nuclear factor-kappaB/RelA and the pathogenesis of psoriasis.

  2014cites this paper